Publications by authors named "Asim Afaq"

Claim this Profile
C
Clinical Implementation of PSMA-PET Guided Tumor Response-Based Boost Adaptation in Online Adaptive Radiotherapy for High-Risk Prostate Cancer.
Ruiqi Li, Mu-Han Lin, Nghi C Nguyen, Fan-Chi Su, David Parsons, Asim Afaq

Cancers (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Applications of PET/MR: Part II: Clinical Applications II.
Andres Kohan, Kate Hanneman, Seyed Ali Mirshahvalad, Asim Afaq, Nadine Mallak

Can Assoc Radiol J· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning applications for quantitative and qualitative PET in PET/MR: technical and clinical unmet needs.
Jaewon Yang, Asim Afaq, Robert Sibley, Alan McMilan, Ali Pirasteh

MAGMA· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
68 Ga-PSMA-Avid Intranasal Solitary Fibrous Tumor.
Saima Riaz, Dimitrios Priftakis, Asim Afaq, Irfan Kayani, Jamshed Bomanji

Clin Nucl Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.
Yishen Wang, Joao R Galante, Athar Haroon, Simon Wan, Asim Afaq

Nat Rev Urol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Shih-Hsin Chen, Kenneth Miles, Stuart A Taylor, Balaji Ganeshan, Manuel Rodriquez, Asim Afaq

Eur J Nucl Med Mol Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis.
Shih-Hsin Chen, Kenneth Miles, Stuart A Taylor, Balaji Ganeshan, Manuel Rodriquez, Asim Afaq

Eur J Nucl Med Mol Imaging· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pitfalls on PET/MRI.
Asim Afaq, David Faul, Venkata Veerendranadh Chebrolu, Simon Wan, Thomas A Hope

Semin Nucl Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Texture Analysis of Fractional Water Content Images Acquired during PET/MRI: Initial Evidence for an Association with Total Lesion Glycolysis, Survival and Gene Mutation Profile in Primary Colorectal Cancer.
Balaji Ganeshan, Kenneth Miles, Asim Afaq, Shonit Punwani, Manuel Rodriguez

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II, Open-label study to assess safety and management change using Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
Asim Afaq, Heather Payne, Reena Davda, John Hines, Gary J R Cook

J Nucl Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of F-Fluciclovine Positron Emission Tomography on the Management of Patients With Recurrence of Prostate Cancer: Results From the FALCON Trial.
Andrew F Scarsbrook, David Bottomley, Eugene J Teoh, Kevin M Bradley, Heather Payne, Asim Afaq

Int J Radiat Oncol Biol Phys· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging of Prostate Cancer Recurrence in the Vas Deferens With 68Ga-PSMA PET/CT.
Dimitrios Priftakis, Asim Afaq, Jamshed Bomanji

Clin Nucl Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is it time to fund routine NHS usage of PSMA PET-CT?
Asim Afaq, Peter J Ell, Jamshed B Bomanji

Nucl Med Commun· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in glucoCEST MR body imaging at 3 Tesla.
Mina Kim, Francisco Torrealdea, Sola Adeleke, Marilena Rega, Vincent Evans, Asim Afaq

Quant Imaging Med Surg· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI.
Maira Hameed, Balaji Ganeshan, Joshua Shur, Subhabrata Mukherjee, Asim Afaq

Int Urol Nephrol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging.
Asim Afaq, Fergus Gleeson, Andrew Scarsbrook, Kevin Bradley, Manil Subesinghe

Nucl Med Commun· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility of prostate cancer heterogeneity using texture analysis of multiparametric MRI.
Maira Hameed, Balaji Ganeshan, Joshua Shur, Subhabrata Mukherjee, Asim Afaq

Int Urol Nephrol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Medhat Aker, Balaji Ganeshan, Asim Afaq, Simon Wan, Ashley M Groves

Dis Colon Rectum· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
68Ga-Prostate-Specific Membrane Antigen PET/CT: Incidental Finding of a Liposarcoma.
Vincenzo Militano, Asim Afaq, Jamshed Bomanji

Clin Nucl Med· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer.
Asim Afaq, Jamshed Bomanji

Br Med Bull· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic appearances of prostate utilizing PET-MRI and PET-CT with 68Ga-PSMA, radiolabelled choline and 68Ga-DOTATATE.
Athar Haroon, Asim Afaq, Soujanya Nuthakki, Alex Freeman, Lorenzo Biassoni

Nucl Med Commun· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer Management.
Asim Afaq, Suliman Alahmed, Shih-Hsin Chen, Thabo Lengana, Athar Haroon

J Nucl Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography.
Asim Afaq, Deepak Batura, Jamshed Bomanji

Int Urol Nephrol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Asim Afaq, Francesco Fraioli, Harbir Sidhu, Simon Wan, Shonit Punwani

Clin Nucl Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/MRI in the Upper Abdomen.
Maria Gavra, Rizwan Syed, Francesco Fraioli, Asim Afaq, Jamshed Bomanji

Semin Nucl Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis